None listed
Conditions
Interventions
Oral ingestion of the test food
Oral ingestion of the placebo food
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1 Japanese males who are between 20 and 60 years of age at the time of obtaining consent 2 Participants who are able to come to the clinic on the designated date and have multiple blood samples taken (7 samples/day x 2 observations) 3 Healthy participants* *"Healthy" in this study refers to those who have no serious organ damage or disease and are not receiving any treatment related to them or any kind of drug therapy. Whether or not a participant is "healthy" is based on the participant's report at the start of the study. 4 Participants who have been fully informed of the purpose and content of the study, have the capacity to consent, understands the study, voluntarily volunteers to participate in the study, and are able to give written consent to participate in the study. 5 Participants with a BMI 20 to 24.9 (male)
Exclusion criteria
Exclusion criteria: Participants 1 with chronic diseases or disorders of the liver, biliary tract, digestive system, circulatory system, respiratory system, kidney, urinary system, mental, nervous system, or blood system 2 who are allergic to medicines or food. 3 who have a smoking habit. 4 who may change their lifestyle during the study period (e.g., work at night, travel for long periods, etc.) 5 who are going to the hospital, taking medication, or undergoing medical treatment 6 with lifestyle-related diseases (diabetes, hypertension, dyslipidemia, etc.) such as those whose fasting blood glucose level is in the diabetic range (fasting blood glucose of 126 mg/dL or higher) or those who have been diagnosed in the past 7 with severe anemia 8 who dislike chocolate. 9 who have a habit of taking drugs for the purpose of disease treatment in the past month (excluding those who have taken drugs for headache, menstrual cramps, common cold, etc.). 10 who have received treatment involving hospitalization within the past 6 months. 11 who are aliquor heavy drinkers (more than 60g of alcohol per day e.g., 1500ml of beer, 2.5 g of sake, approximately 200ml of whiskey straight) 12 who are currently participating in another clinical trial, will participate in another clinical trial within 4 weeks after the completion of the trial, or will participate in another clinical trial after agreeing to participate in the said trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Analysis and Questionnaire | — |
Countries
Japan
Contacts
Public ContactHiroko Uchida
Morinaga & Co., Ltd. R&D institute
Outcome results
None listed